| Molecular Formula: | |
|---|---|
| Molecular Formula | C22H17ClN6O |
| Molecular Weight: | |
| Molecular Weight | 416.86 |
| COA: | |
| COA | Inquire |
| Targets: | |
| Targets | PI3K |
| Description: | |
| Description | The R isomer analogue of Duvelisib which is a high selective PI3K δ/γ inhibitor. |
| Purity: | |
|---|---|
| Purity | 95% |
| Appearance: | |
| Appearance | Powder |
| Synonyms: | |
| Synonyms | IPI-145 R enantiomer; IPI 145 R enantiomer; IPI145 R enantiomer; INK1197 R enantiomer; INK 1197 R enantiomer; INK-1197 R enantiomer |
| Solubility: | |
| Solubility | DMSO |
| Storage: | |
| Storage | -20ºC Freeze |
| MSDS: | |
| MSDS | Inquire |
| Application: | |
| Application | The R isomer analogue of Duvelisib which is a high selective PI3K δ/γ inhibitor. |
| Shelf Life: | |
| Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
| Quantity: | |
|---|---|
| Quantity | Milligrams-Grams |
| InChIKey: | |
| InChIKey | SJVQHLPISAIATJ-CYBMUJFWSA-N |
| InChI: | |
| InChI | InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m1/s1 |
| Canonical SMILES: | |
| Canonical SMILES | CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 |
Related PI3K Products
AS-252424
(CAS: 900515-16-4)
AS-252424 is a novel, potent PI3Kγ inhibitor (IC50 of 30 nM) with a 30-fold selectivity for PI3Kγ than PI3Kα, and low inhibitory activity towards PI3Kδ/β.
GDC0941
(CAS: 957054-30-7)
GDC-0941 is a potent pan inhibitor of class I catalytic subunits of PI3K that inhibits p110α, β, δ, and γ with IC50 values of 3, 33, 3, and 75 nM.
LY294002
(CAS: 154447-36-6)
LY294002 is a potent inhibitor of phosphoinositide PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM, respectively.
NSC 66389,3-MA
(CAS: 5142-23-4)
GSK2269557
(CAS: 1254036-71-9)
GSK2269557, an effective PI3K inhibitor, could be used as against inflammatory and some autoimmune diseases. It has just completes a phase II trial against Asth...
Vps34-PIK-III
(CAS: 1383716-40-2)
Vps34-PIK-III is a potent and selective inhibitor of the type 3 phosphatidylinositol 3-kinase (PI3K) vacuolar protein sorting 34 (Vps34) (IC50= 18 nM). Vps34-PI...
AZD6482
(CAS: 1173900-33-8)
AZD6482 is a PI3Kβ inhibitor with IC50 of 10 nM, 8-, 87- and 109-fold more selective to PI3Kβ than PI3Kδ, PI3Kα and PI3Kγ. Phase 1.
ZSTK474
(CAS: 475110-96-4)
ZSTK474 is a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, which strongly inhibits cancer cell proliferation. Phosphoinositide 3-kinase (PI3K) is a pote...
GSK2636771
(CAS: 1372540-25-4)
GSK2636771 is an orally bioavailable, substituted benzimidazole inhibitor of the class I phosphoinositide 3-kinase (PI3K) beta isoform with potential antineopla...
NVP-BBD130
(CAS: 853910-61-9)
NVP-BBD130 is a potent and selective dual PI3K/mTOR inhibitor. It can suppress the growth and proliferation of melanoma primary tumors and metastasis via inhibi...
NSC781406
(CAS: 1676893-24-5)
NSC781406 demonstrates potent PI3K inhibition (PI3Kα IC50=2.0 nM) and is a highly potent mTOR inhibitor, with reasonable liver microsome stability.
NVP-BKM120 Hydrochloride
(CAS: 1312445-63-8)
NVP-BKM120 Hcl(BKM120) is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM, respectively.
Copanlisib
(CAS: 1032568-63-0)
Copanlisib is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BAY 80-6946 inhibits the activation of the PI3K signaling pat...
Seletalisib
(CAS: 1362850-20-1)
Seletalisib is a selective Phosphatidylinositol 3 kinase delta inhibitor originated by UCB.It is a Immunomodulator. Phaes I clinical trials for Plaque psoriasis...
ON 146040
(CAS: 1404231-34-0)
ON 146040 was highly potent in killing hematologic tumor cells with IC50 values in the 150 to 1,000 nM range. In biochemical testing, ON 146040 inhibited PI3K α...
BKM120
(CAS: 1202777-78-3)
BKM120, also called as buparlisib or NVP-BKM120, activity in a range of preclinical cancermodels, specifically inhbits class I PI3K isoforms, which blocks p110α...